BBP
Virtus LifeSci Biotech Products
BBP
61,94
0,02 Bil. AUM
0,8% Expense Ratio
60,11 NAV
Virtus LifeSci Biotech Products Profile
About Virtus LifeSci Biotech Products
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
- Company
- Holdings
- 198
- CUSIP
- 26923G202
Virtus LifeSci Biotech Products Sectors
| Industry | Percentage |
|---|---|
| Healthcare | 100,00% |
| Basic Materials | 0,00% |
| Technology | 0,00% |
| Real Estate | 0,00% |
| Industrials | 0,00% |
| Financial Servic | 0,00% |
| Energy | 0,00% |
| Consumer Defensi | 0,00% |
| Consumer Cyclica | 0,00% |
| Communication Se | 0,00% |
| Utilities | 0,00% |